Pfizer is withdrawing Bextra from the market due to reports of serious skin reactions and an increased risk of cardiovascular side effects.
Director of Public Health Dr. Kiran Kumar is advising the public to stop taking Bextra and to consult a pharmacist or physician for a suitable alternative.
Bextra (chemical name valdecoxib) is a non steroidal anti-inflammatory prescription drug that is generally used for the reduction of pain and inflammation caused by osteoarthritis. It is also used for acute pain in adults and treatment of menstrual pain, says a release from Government Information Services.
Dr. Kumar said in the release that there is no need for panic and the withdrawal of Bextra is a precautionary measure only.